XRCC5 and neoplasm: Immunohistochemical (IHC) staining of tumor samples from 60 patients revealed higher levels of phosphorylated DNA-PKcs and KU80 in DDP-resistant tumors compared to DDP-sensitive ones (Fig. 1N-O, Figure S7A).